Global Trends in Research on MOG Antibody-associated Disease: Bibliometrics and Visualization Analysis

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Feb 19

PMID 38370410

Authors

Shuhan Zheng

Yang Wang

Jiaming Geng

Xueyan Liu

Liang Huo

Affiliations

Soon will be listed here.

Abstract

Objective: The purpose of this study was to investigate the current research status, focus areas, and developmental trends in the field of Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) through an analysis of scientific literature.

Methods: The relevant research articles on MOGAD published from 1947 to 2022 were retrieved from the Web of Science database. The quantitative output of MOGAD related research articles, their distribution by country/region, data on collaborative publishing, influential authors, high-yield institutions, keywords, hotspots, and development trends were analyzed. Additionally, visual knowledge maps were generated using VOSviewer and Citespace.

Results: There has been a steady increase in the number of MOGAD related publications indicating that the subject has garnered increasing interest among researchers globally. The United States has been the leading contributor with 496 papers (19.25%), followed by China (244, 9.63%), Japan (183, 7.10%), the United Kingdom (154, 5.98%), and Germany (149, 5.78%). Among these countries, the United Kingdom boasts the highest citation frequency at the rate of 46.49 times per paper. Furthermore, active collaboration in MOGAD related research is observed primarily between the United States and countries such as Canada, Germany, Australia, Italy, the United Kingdom and Japan. Mayo Clinic ranks first in total articles published (109) and frequency of citations per article (77.79). Takahashi Toshiyuki from Tohoku University is the most prolific author, while is the most widely read journal in this field. "Disease Phenotype", "Treatment", "Novel Coronavirus Infection and Vaccination", "Immunopathological Mechanisms", "Clinical characteristics of children" and "Prognosis" are the primary keywords clusters in this field. "Novel Coronavirus Infection and Vaccination" and "Immunopathological Mechanisms" are research hotspots and have great development potential.

Conclusion: The past three decades have witnessed a significant expansion of research on MOGAD. The pathogenetic mechanism of MOGAD is poised to be the prominent research focus in this field in the foreseeable future.

Citing Articles

Community Integration of Disability: A Bibliometric and Knowledge-Map Analysis.

Wang S, Li D, Liu C, Sun X, Shi Y, Wang H J Multidiscip Healthc. 2025; 18:339-353.

PMID: 39872871 PMC: 11769851. DOI: 10.2147/JMDH.S494130.

Research hotspots and trends in diabetes and insulin resistance: a bibliometric analysis.

Zhang S, Yan H, Cao D, Sun W, Li J, Xu J Front Nutr. 2024; 11:1480491.

PMID: 39737158 PMC: 11684393. DOI: 10.3389/fnut.2024.1480491.

A bibliometric analysis of domestic and international research on hemorrhagic fever with renal syndrome over the past 2 decades.

Zhou W, Dong Y, Liu X, Ding S, Si H, Yang C Medicine (Baltimore). 2024; 103(37):e39737.

PMID: 39287241 PMC: 11404925. DOI: 10.1097/MD.0000000000039737.

References

Rechtman A, Brill L, Zveik O, Uliel B, Haham N, Bick A . Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course. Front Neurol. 2022; 13:867190. PMC: 8987978. DOI: 10.3389/fneur.2022.867190. View

Winklmeier S, Schluter M, Spadaro M, Thaler F, Vural A, Gerhards R . Identification of circulating MOG-specific B cells in patients with MOG antibodies. Neurol Neuroimmunol Neuroinflamm. 2019; 6(6):625. PMC: 6857907. DOI: 10.1212/NXI.0000000000000625. View

Gunashekar S, Wooding S, Guthrie S . How do NIHR peer review panels use bibliometric information to support their decisions?. Scientometrics. 2017; 112(3):1813-1835. PMC: 5533850. DOI: 10.1007/s11192-017-2417-8. View

Baumann M, Bartels F, Finke C, Adamsbaum C, Hacohen Y, Rostasy K . E.U. paediatric MOG consortium consensus: Part 2 - Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol. 2020; 29:14-21. DOI: 10.1016/j.ejpn.2020.10.002. View

Krupp L, Tardieu M, Amato M, Banwell B, Chitnis T, Dale R . International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013; 19(10):1261-7. DOI: 10.1177/1352458513484547. View

Kogure C, Kikushima W, Fukuda Y, Hasebe Y, Takahashi T, Shibuya T . Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: A case report. Medicine (Baltimore). 2021; 100(19):e25865. PMC: 8133173. DOI: 10.1097/MD.0000000000025865. View

Hacohen Y, Rossor T, Mankad K, Chong W, Lux A, Wassmer E . 'Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease. Dev Med Child Neurol. 2017; 60(4):417-423. DOI: 10.1111/dmcn.13649. View

Hacohen Y, Banwell B . Treatment Approaches for MOG-Ab-Associated Demyelination in Children. Curr Treat Options Neurol. 2019; 21(1):2. PMC: 6342853. DOI: 10.1007/s11940-019-0541-x. View

Bruijstens A, Lechner C, Flet-Berliac L, Deiva K, Neuteboom R, Hemingway C . E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol. 2020; 29:2-13. DOI: 10.1016/j.ejpn.2020.10.006. View

10.

Hacohen Y, Wong Y, Lechner C, Jurynczyk M, Wright S, Konuskan B . Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. JAMA Neurol. 2018; 75(4):478-487. PMC: 5885190. DOI: 10.1001/jamaneurol.2017.4601. View

11.

Pandit L, Sudhir A, Malli C, DCunha A . COVID-19 infection and vaccination against COVID-19: Impact on managing demyelinating CNS disorders in Southern India- experience from a demyelinating disease registry. Mult Scler Relat Disord. 2022; 66:104033. PMC: 9252866. DOI: 10.1016/j.msard.2022.104033. View

12.

Hou C, Wu W, Tian Y, Zhang Y, Zhu H, Zeng Y . Clinical analysis of anti-NMDAR encephalitis combined with MOG antibody in children. Mult Scler Relat Disord. 2020; 42:102018. DOI: 10.1016/j.msard.2020.102018. View

13.

Chen J, Flanagan E, Bhatti M, Jitprapaikulsan J, Dubey D, Lopez Chiriboga A . Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder. Neurology. 2020; 95(2):e111-e120. PMC: 7455322. DOI: 10.1212/WNL.0000000000009758. View

14.

OConnor K, McLaughlin K, De Jager P, Chitnis T, Bettelli E, Xu C . Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med. 2007; 13(2):211-7. PMC: 3429369. DOI: 10.1038/nm1488. View

15.

Sen S, Tuncer A, Ozakbas S, Uzunkopru C, Baba C, Demir S . The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?. Mult Scler Relat Disord. 2022; 58:103399. PMC: 8655726. DOI: 10.1016/j.msard.2021.103399. View

16.

Ullah R, Asghar I, Griffiths M . An Integrated Methodology for Bibliometric Analysis: A Case Study of Internet of Things in Healthcare Applications. Sensors (Basel). 2023; 23(1). PMC: 9824791. DOI: 10.3390/s23010067. View

17.

Jurynczyk M, Messina S, Woodhall M, Raza N, Everett R, Roca-Fernandez A . Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017; 140(12):3128-3138. DOI: 10.1093/brain/awx276. View

18.

Zhou J, Lu X, Zhang Y, Ji T, Jin Y, Xu M . Follow-up study on Chinese children with relapsing MOG-IgG-associated central nervous system demyelination. Mult Scler Relat Disord. 2018; 28:4-10. DOI: 10.1016/j.msard.2018.12.001. View

19.

Zhao-Fleming H, Valencia Sanchez C, Sechi E, Inbarasu J, Wijdicks E, Pittock S . CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies. Neurology. 2021; 97(13):e1351-e1358. PMC: 8480400. DOI: 10.1212/WNL.0000000000012599. View

20.

Wong Y, Hacohen Y, Armangue T, Wassmer E, Verhelst H, Hemingway C . Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome. Eur J Neurol. 2018; 25(5):782-786. DOI: 10.1111/ene.13602. View